{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:04:06Z","timestamp":1779372246111,"version":"3.53.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2014,2,23]],"date-time":"2014-02-23T00:00:00Z","timestamp":1393113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00018-014-1584-5","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T05:23:42Z","timestamp":1393046622000},"page":"2865-2878","source":"Crossref","is-referenced-by-count":28,"title":["Role of microRNAs in malignant mesothelioma"],"prefix":"10.1007","volume":"71","author":[{"given":"A.","family":"Truini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Genova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Dal Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rijavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Burrafato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,23]]},"reference":[{"key":"1584_CR1","first-page":"260","volume":"17","author":"JC Wagner","year":"1960","unstructured":"Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260\u2013271","journal-title":"Br J Ind Med"},{"issue":"Suppl 2","key":"1584_CR2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1289\/ehp.99107s2289","volume":"107","author":"M Albin","year":"1999","unstructured":"Albin M, Magnani C, Krstev S, Rapiti E, Sheferl I (1999) Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 107(Suppl 2):289\u2013298","journal-title":"Environ Health Perspect"},{"key":"1584_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","volume":"13","author":"R Ismail-Khan","year":"2006","unstructured":"Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR (2006) Malignant pleural mesothelioma: a comprehensive review. Cancer Control 13:255\u2013263","journal-title":"Cancer Control"},{"key":"1584_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","volume":"29","author":"M Carbone","year":"2002","unstructured":"Carbone M, Kratzke RA, Testa JR (2002) The pathogenesis of mesothelioma. Semin Oncol 29:2\u201317","journal-title":"Semin Oncol"},{"key":"1584_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14737140.8.2.293","volume":"8","author":"AJ Kaufman","year":"2008","unstructured":"Kaufman AJ, Pass HI (2008) Current concepts in malignant pleural mesothelioma. Expert Rev Anticancer Ther 8:293\u2013303","journal-title":"Expert Rev Anticancer Ther"},{"key":"1584_CR6","first-page":"32","volume":"9","author":"A Bridda","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M (2007) Peritoneal mesothelioma: a review. MedGenMed 9:32","journal-title":"MedGenMed"},{"key":"1584_CR7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M, International Mesothelioma Interest Group (2013) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137:647\u2013667","journal-title":"Arch Pathol Lab Med"},{"key":"1584_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397\u2013408","journal-title":"Lancet"},{"key":"1584_CR9","first-page":"919","volume":"13","author":"SC Grondin","year":"1999","unstructured":"Grondin SC, Sugarbaker DJ (1999) Malignant mesothelioma of the pleural space. Oncology (Williston Park) 13:919\u2013926 (discussion 926, 931\u2013932)","journal-title":"Oncology (Williston Park)"},{"key":"1584_CR10","first-page":"319","volume":"110","author":"V Neumann","year":"2013","unstructured":"Neumann V, L\u00f6seke S, Nowak D, Herth FJ, Tannapfel A (2013) Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int 110:319\u2013326","journal-title":"Dtsch Arztebl Int"},{"key":"1584_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00104-012-2432-5","volume":"84","author":"S B\u00f6l\u00fckbas","year":"2013","unstructured":"B\u00f6l\u00fckbas S, Schirren J (2013) Malignant pleural mesothelioma : Comparison of radical pleurectomy und extrapleural pneumonectomy. Chirurg 84:487\u2013491","journal-title":"Chirurg"},{"key":"1584_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-10862-4_7","volume":"189","author":"D Rice","year":"2011","unstructured":"Rice D (2011) Surgical therapy of mesothelioma. Recent Results Cancer Res 189:97\u2013125","journal-title":"Recent Results Cancer Res"},{"key":"1584_CR13","first-page":"428","volume":"1","author":"C Cao","year":"2012","unstructured":"Cao C, Tian D, Manganas C, Matthews P, Yan TD (2012) Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 1:428\u2013437","journal-title":"Ann Cardiothorac Surg"},{"key":"1584_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11864-011-0154-4","volume":"12","author":"AJ Kaufman","year":"2011","unstructured":"Kaufman AJ, Flores RM (2011) Surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol 12:201\u2013216","journal-title":"Curr Treat Options Oncol"},{"key":"1584_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","volume":"31","author":"EG Butchart","year":"1976","unstructured":"Butchart EG, Ashcroft T, Barnsley WC, Holden MP (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31:15\u201324","journal-title":"Thorax"},{"key":"1584_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.athoracsur.2004.01.034","volume":"78","author":"DJ Stewart","year":"2004","unstructured":"Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O\u2019Byrne KJ, Waller DA (2004) The effect of extent of local resection on patterns of disease progression in malignant mesothelioma. Ann Thorac Surg 78:245\u2013252","journal-title":"Ann Thorac Surg"},{"key":"1584_CR17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, Snee M, O\u2019Brien M, Thomas G, Senan S, O\u2019Byrne K, Kilburn LS, Spicer J, Landau D, Edwards J, Coombes G, Darlison L, Peto J, MARS trialists (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763\u2013772","journal-title":"Lancet Oncol"},{"key":"1584_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1010-7940(96)01008-1","volume":"11","author":"O Soysal","year":"1997","unstructured":"Soysal O, Karao\u011flano\u011flu N, Demiracan S, Top\u00e7u S, Ta\u015ftepe I, Kaya S, Unl\u00fc M, Celtin G (1997) Pleurectomy\/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11:210\u2013213","journal-title":"Eur J Cardiothorac Surg"},{"key":"1584_CR19","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"key":"1584_CR20","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"JP Meerbeeck van","year":"2005","unstructured":"van Meerbeeck JP, Gaafar R, Manegold C, Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G, European Organisation for Research and Treatment of Cancer Lung Cancer Group; National Cancer Institute of Canada (2005) Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23:6881\u20136889","journal-title":"J Clin Oncol"},{"key":"1584_CR21","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2577::AID-CNCR13>3.0.CO;2-S","volume":"85","author":"JP Meerbeeck van","year":"1999","unstructured":"van Meerbeeck JP, Baas P, Debruyne C, Groen HJ, Manegold C, Ardizzoni A, Gridelli C, van Marck EA, Lentz M, Giaccone G (1999) A phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Cancer 85:2577\u20132582","journal-title":"Cancer"},{"key":"1584_CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2008.04.001","volume":"63","author":"J Stebbing","year":"2009","unstructured":"Stebbing J, Powles T, McPherson K, Shamash J, Wells P, Sheaff MT, Slater S, Rudd RM, Fennell D, Steele JP (2009) The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer 63:94\u201397","journal-title":"Lung Cancer"},{"key":"1584_CR23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","volume":"35","author":"A Scherpereel","year":"2010","unstructured":"Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Galateau-Salle F, Hennequin C, Hillerdal G, Le P\u00e9choux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W, European Respiratory Society\/European Society of Thoracic Surgeons Task Force (2010) Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleura mesothelioma. Eur Respir J 35:479\u2013495","journal-title":"Eur Respir J"},{"key":"1584_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-642-10862-4_8","volume":"189","author":"X Dhalluin","year":"2011","unstructured":"Dhalluin X, Scherpereel A (2011) Chemotherapy and radiotherapy for mesothelioma. Recent Results Cancer Res 189:127\u2013147","journal-title":"Recent Results Cancer Res"},{"key":"1584_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2008-1076790","volume":"133","author":"W Sienel","year":"2008","unstructured":"Sienel W, Kirschbaum A, Passlick B (2008) Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy. Zentralbl Chir 133:231\u2013237","journal-title":"Zentralbl Chir"},{"key":"1584_CR26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000658-199609000-00005","volume":"224","author":"DJ Sugarbaker","year":"1996","unstructured":"Sugarbaker DJ, Garcia JP, Richards WG, Harpole DH Jr, Healy-Baldini E, DeCamp MM Jr, Mentzer SJ, Liptay MJ, Strauss GM, Swanson SJ (1996) Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 224:288\u2013294 (discussion 294\u2013296)","journal-title":"Ann Surg"},{"key":"1584_CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-10862-4_10","volume":"189","author":"S Klebe","year":"2011","unstructured":"Klebe S, Henderson DW (2011) Early stages of mesothelioma, screening and biomarkers. Recent Results Cancer Res 189:169\u2013193","journal-title":"Recent Results Cancer Res"},{"key":"1584_CR28","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.119.4.1138","volume":"119","author":"Onetto M Paganuzzi","year":"2011","unstructured":"Paganuzzi Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S, Felletti R (2011) Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest 119:1138\u20131142","journal-title":"Chest"},{"key":"1584_CR29","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-06-0472","volume":"12","author":"M Onda","year":"2006","unstructured":"Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I (2006) Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res 12:4225\u20134423","journal-title":"Clin Cancer Res"},{"key":"1584_CR30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","volume":"353","author":"HI Pass","year":"2005","unstructured":"Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 353:1564\u20131573","journal-title":"N Engl J Med"},{"key":"1584_CR31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I (2003) Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362:1612\u20131616","journal-title":"Lancet"},{"key":"1584_CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"1584_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259\u2013269","journal-title":"Nat Rev Cancer"},{"key":"1584_CR34","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.febslet.2005.09.040","volume":"579","author":"I Bentwich","year":"2005","unstructured":"Bentwich I (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579:5904\u20135910","journal-title":"FEBS Lett"},{"key":"1584_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","volume":"136","author":"D Jean","year":"2012","unstructured":"Jean D, Daubriac J, Le Pimpec-Barthes F, Galateau-Salle F, Jaurand MC (2012) Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med 136:277\u2013293","journal-title":"Arch Pathol Lab Med"},{"key":"1584_CR36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt1392","volume":"26","author":"N Rosenfeld","year":"2008","unstructured":"Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, Barshack I (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26:462\u2013469","journal-title":"Nat Biotechnol"},{"key":"1584_CR37","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3:e3148","journal-title":"PLoS One"},{"key":"1584_CR38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733\u20131741","journal-title":"Clin Chem"},{"key":"1584_CR39","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O\u2019Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513\u201310518","journal-title":"Proc Natl Acad Sci USA"},{"key":"1584_CR40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997\u20131006","journal-title":"Cell Res"},{"key":"1584_CR41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57:833\u2013840","journal-title":"Clin Chem"},{"key":"1584_CR42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1566524011313050006","volume":"13","author":"M Fabbri","year":"2013","unstructured":"Fabbri M (2013) MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med 13:751\u2013756","journal-title":"Curr Mol Med"},{"key":"1584_CR43","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524\u201315529","journal-title":"Proc Natl Acad Sci USA"},{"key":"1584_CR44","first-page":"950201","volume":"2009","author":"HM Heneghan","year":"2009","unstructured":"Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ (2009) MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009:950201","journal-title":"J Oncol"},{"key":"1584_CR45","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","volume":"24","author":"C Roldo","year":"2006","unstructured":"Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677\u20134684","journal-title":"J Clin Oncol"},{"key":"1584_CR46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7314\/APJCP.2013.14.2.1057","volume":"14","author":"YZ Xu","year":"2013","unstructured":"Xu YZ, Xi QH, Ge WL, Zhang XQ (2013) Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pac J Cancer Prev 14:1057\u20131060","journal-title":"Asian Pac J Cancer Prev"},{"key":"1584_CR47","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1158\/0008-5472.CAN-09-0587","volume":"69","author":"M Raponi","year":"2009","unstructured":"Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776\u20135783","journal-title":"Cancer Res"},{"key":"1584_CR48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.thorsurg.2013.01.002","volume":"23","author":"HI Pass","year":"2013","unstructured":"Pass HI, Beer DG, Joseph S, Massion P (2013) Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer. Thorac Surg Clin 23:211\u2013224","journal-title":"Thorac Surg Clin"},{"key":"1584_CR49","doi-asserted-by":"crossref","unstructured":"Nadal E, Chen G, Gallegos M, Lin L, Ferrer-Torres D, Truini A, Wang Z, Lin J, Reddy RM, Llatjos R, Escobar I, Moya J, Chang AC, Cardenal F, Capella G, Beer DG (2013) Epigenetic inactivation of microRNA-34b\/c predicts poor disease-free survival in early stage lung adenocarcinoma. Clin Cancer Res\u00a019:6842\u20136852","DOI":"10.1158\/1078-0432.CCR-13-0736"},{"key":"1584_CR50","first-page":"420","volume":"33","author":"C Minoia","year":"2011","unstructured":"Minoia C, Sturchio E, Porro B, Ficociello B, Zambelli A, Imbriani M (2011) MicroRNAs as biological indicators of environmental and occupational exposure to asbestos. G Ital Med Lav Ergon 33:420\u2013434","journal-title":"G Ital Med Lav Ergon"},{"key":"1584_CR51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"1584_CR52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tibtech.2007.11.007","volume":"26","author":"JQ Yin","year":"2008","unstructured":"Yin JQ, Zhao RC, Morris KV (2008) Profiling microRNA expression with microarrays. Trends Biotechnol 26:70\u201376","journal-title":"Trends Biotechnol"},{"key":"1584_CR53","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1093\/nar\/gni178","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179","journal-title":"Nucleic Acids Res"},{"key":"1584_CR54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","volume":"48","author":"M Guled","year":"2009","unstructured":"Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014a miRNA microarray analysis. Genes Chromosomes Cancer 48:615\u2013623","journal-title":"Genes Chromosomes Cancer"},{"key":"1584_CR55","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","volume":"6","author":"L Santarelli","year":"2011","unstructured":"Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, Pozzi V, Carbonari D, Bracci M, Pignotti E, Mazzanti P, Sabbatini A, Ranaldi R, Gasparini S, Neuzil J, Tomasetti M (2011) Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS One 6:e18232","journal-title":"PLoS One"},{"key":"1584_CR56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.lungcan.2009.01.010","volume":"66","author":"B Liu","year":"2009","unstructured":"Liu B, Peng XC, Zheng XL, Wang J, Qin YW (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66:169\u2013175","journal-title":"Lung Cancer"},{"key":"1584_CR57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2012.02.009","volume":"45","author":"M Tomasetti","year":"2012","unstructured":"Tomasetti M, Staffolani S, Nocchi L, Neuzil J, Strafella E, Manzella N, Mariotti L, Bracci M, Valentino M, Amati M, Santarelli L (2012) Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin Biochem 45:575\u2013581","journal-title":"Clin Biochem"},{"key":"1584_CR58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","volume":"12","author":"H Benjamin","year":"2010","unstructured":"Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, Ashkenazi K, Goren E, Meiri E, Morgenstern S, Perelman M, Barshack I, Goren Y, Edmonston TB, Chajut A, Aharonov R, Bentwich Z, Rosenfeld N, Cohen D (2010) A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 12:771\u2013779","journal-title":"J Mol Diagn"},{"key":"1584_CR59","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","volume":"127","author":"GV Gee","year":"2010","unstructured":"Gee GV, Koestler DC, Christensen BC, Sugarbaker DJ, Ugolini D, Ivaldi GP, Resnick MB, Houseman EA, Kelsey KT, Marsit CJ (2010) Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer 127:2859\u20132869","journal-title":"Int J Cancer"},{"key":"1584_CR60","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257\u20132261","journal-title":"Proc Natl Acad Sci USA"},{"key":"1584_CR61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","volume":"42","author":"S Busacca","year":"2010","unstructured":"Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G (2010) MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 42:312\u2013319","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1584_CR62","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1600-0463.2012.02891.x","volume":"120","author":"M Andersen","year":"2012","unstructured":"Andersen M, Grauslund M, Muhammad-Ali M, Ravn J, S\u00f8rensen JB, Andersen CB, Santoni-Rugiu E (2012) Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma? APMIS 120:767\u2013769","journal-title":"APMIS"},{"key":"1584_CR63","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","volume":"6","author":"V Balatti","year":"2011","unstructured":"Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, Martini F, Tognon MG (2011) MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 6:844\u2013851","journal-title":"J Thorac Oncol"},{"key":"1584_CR64","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","volume":"70","author":"HI Pass","year":"2010","unstructured":"Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R (2010) hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res 70:1916\u20131924","journal-title":"Cancer Res"},{"key":"1584_CR65","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","volume":"7","author":"MB Kirschner","year":"2012","unstructured":"Kirschner MB, Cheng YY, Badrian B, Kao SC, Creaney J, Edelman JJ, Armstrong NJ, Vallely MP, Musk AW, Robinson BW, McCaughan BC, Klebe S, Mutsaers SE, van Zandwijk N, Reid G (2012) Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma. J Thorac Oncol 7:1184\u20131191","journal-title":"J Thorac Oncol"},{"key":"1584_CR66","doi-asserted-by":"crossref","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","volume":"7","author":"DG Weber","year":"2012","unstructured":"Weber DG, Johnen G, Bryk O, J\u00f6ckel KH, Br\u00fcning T (2012) Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma\u2014a pilot study. PLoS ONE 7:e30221","journal-title":"PLoS ONE"},{"key":"1584_CR67","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","volume":"104","author":"M Fabbri","year":"2007","unstructured":"Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104:15805\u201315810","journal-title":"Proc Natl Acad Sci USA"},{"key":"1584_CR68","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590\u201311593","journal-title":"Cancer Res"},{"key":"1584_CR69","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/embor.2009.9","volume":"10","author":"CA Gebeshuber","year":"2009","unstructured":"Gebeshuber CA, Zatloukal K, Martinez J (2009) miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10:400\u2013405","journal-title":"EMBO Rep"},{"key":"1584_CR70","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.23949","volume":"124","author":"SV Ivanov","year":"2009","unstructured":"Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI (2009) Genomic events associated with progression of pleural malignant mesothelioma. Int J Cancer 124:589\u2013599","journal-title":"Int J Cancer"},{"key":"1584_CR71","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","volume":"285","author":"SV Ivanov","year":"2010","unstructured":"Ivanov SV, Goparaju CM, Lopez P, Zavadil J, Toren-Haritan G, Rosenwald S, Hoshen M, Chajut A, Cohen D, Pass HI (2010) Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem 285:22809\u201322817","journal-title":"J Biol Chem"},{"key":"1584_CR72","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","volume":"17","author":"T Kubo","year":"2011","unstructured":"Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, Nasu Y, Kishimoto T, Pass HI, Matsui H, Huh NH, Miyoshi S (2011) Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 17:4965\u20134974","journal-title":"Clin Cancer Res"},{"key":"1584_CR73","first-page":"4871","volume":"32","author":"Y Maki","year":"2012","unstructured":"Maki Y, Asano H, Toyooka S, Soh J, Kubo T, Katsui K, Ueno T, Shien K, Muraoka T, Tanaka N, Yamamoto H, Tsukuda K, Kishimoto T, Kanazawa S, Miyoshi S (2012) MicroRNA miR-34b\/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells. Anticancer Res 32:4871\u20134875","journal-title":"Anticancer Res"},{"key":"1584_CR74","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","volume":"29","author":"N Tanaka","year":"2013","unstructured":"Tanaka N, Toyooka S, Soh J, Tsukuda K, Shien K, Furukawa M, Muraoka T, Maki Y, Ueno T, Yamamoto H, Asano H, Otsuki T, Miyoshi S (2013) Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol Rep 29:2169\u20132174","journal-title":"Oncol Rep"},{"key":"1584_CR75","doi-asserted-by":"crossref","unstructured":"Muraoka T, Soh J, Toyooka S, Aoe K, Fujimoto N, Hashida S, Maki Y, Tanaka N, Shien K, Furukawa M, Yamamoto H, Asano H, Tsukuda K, Kishimoto T, Otsuki T, Miyoshi S (2013) The degree of microRNA-34b\/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma. Lung Cancer [Epub ahead of print]","DOI":"10.1016\/j.lungcan.2013.09.017"},{"key":"1584_CR76","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","volume":"18","author":"N Khodayari","year":"2011","unstructured":"Khodayari N, Mohammed KA, Goldberg EP, Nasreen N (2011) EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene. Cancer Gene Ther 18:806\u2013816","journal-title":"Cancer Gene Ther"},{"key":"1584_CR77","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/onc.2010.643","volume":"30","author":"CM Goparaju","year":"2011","unstructured":"Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI (2011) ONCONASE-mediated NFK\u03b2 downregulation in malignant pleural mesothelioma. Oncogene 30:2767\u20132777","journal-title":"Oncogene"},{"key":"1584_CR78","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/0008-5472.CAN-07-6655","volume":"68","author":"J Datta","year":"2008","unstructured":"Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST (2008) Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68:5049\u20135058","journal-title":"Cancer Res"},{"key":"1584_CR79","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/bjc.2011.23","volume":"104","author":"H Yoshino","year":"2011","unstructured":"Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M (2011) The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104:808\u2013818","journal-title":"Br J Cancer"},{"key":"1584_CR80","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","volume":"144","author":"Y Xu","year":"2013","unstructured":"Xu Y, Zheng M, Merritt RE, Shrager JB, Wakelee H, Kratzke RA, Hoang CD (2013) miR-1 induces growth arrest and apoptosis in malignant mesothelioma. Chest 144:1632\u20131643","journal-title":"Chest"},{"key":"1584_CR81","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D\u2019Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14:1271\u20131277","journal-title":"Nat Med"},{"key":"1584_CR82","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-08-4277","volume":"69","author":"N Bandi","year":"2009","unstructured":"Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69:5553\u20135559","journal-title":"Cancer Res"},{"key":"1584_CR83","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12032-011-9880-5","volume":"29","author":"X Wang","year":"2012","unstructured":"Wang X, Wang J, Ma H, Zhang J, Zhou X (2012) Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 29:919\u2013927","journal-title":"Med Oncol"},{"key":"1584_CR84","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","volume":"69","author":"R Bhattacharya","year":"2009","unstructured":"Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee P (2009) MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 69:9090\u20139095","journal-title":"Cancer Res"},{"key":"1584_CR85","doi-asserted-by":"crossref","unstructured":"Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, Brahmbhatt H, Macdiarmid JA, van Zandwijk N (2013) Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann Oncol\u00a024:3128\u20133135","DOI":"10.1093\/annonc\/mdt412"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1584-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-014-1584-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-014-1584-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:41:13Z","timestamp":1565214073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-014-1584-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,23]]},"references-count":85,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1007\/s00018-014-1584-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,23]]}}}